Renaissance Technologies’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-85,113
| Closed | -$25K | – | 4281 |
|
2023
Q3 | $25K | Sell |
85,113
-5,287
| -6% | -$1.55K | ﹤0.01% | 3505 |
|
2023
Q2 | $44K | Sell |
90,400
-59,900
| -40% | -$29.2K | ﹤0.01% | 3640 |
|
2023
Q1 | $95K | Sell |
150,300
-26,242
| -15% | -$16.6K | ﹤0.01% | 3506 |
|
2022
Q4 | $81K | Buy |
176,542
+131,142
| +289% | +$60.2K | ﹤0.01% | 3687 |
|
2022
Q3 | $38K | Buy |
45,400
+13,300
| +41% | +$11.1K | ﹤0.01% | 3823 |
|
2022
Q2 | $37K | Sell |
32,100
-7,600
| -19% | -$8.76K | ﹤0.01% | 4048 |
|
2022
Q1 | $51K | Sell |
39,700
-59,300
| -60% | -$76.2K | ﹤0.01% | 3914 |
|
2021
Q4 | $161K | Buy |
99,000
+87,100
| +732% | +$142K | ﹤0.01% | 3589 |
|
2021
Q3 | $33K | Sell |
11,900
-20,546
| -63% | -$57K | ﹤0.01% | 3395 |
|
2021
Q2 | $98K | Sell |
32,446
-108,754
| -77% | -$328K | ﹤0.01% | 3360 |
|
2021
Q1 | $574K | Buy |
141,200
+10,700
| +8% | +$43.5K | ﹤0.01% | 2857 |
|
2020
Q4 | $608K | Sell |
130,500
-99,400
| -43% | -$463K | ﹤0.01% | 2735 |
|
2020
Q3 | $945K | Buy |
+229,900
| New | +$945K | ﹤0.01% | 2550 |
|